Morning Business Report: Medicare obesity coverage drives GLP-1 use as Disney promotions boost park attendance

Eli Lilly CEO Dave Ricks says 700,000 new seniors have started GLP-1 treatments since Medicare coverage for obesity drugs launched in July.
Morning Business Report: Medicare Obesity Coverage Drives Glp 1 Use As Disney Promotions Boost Park Attendance

(LILAMAX)- Eli Lilly CEO Dave Ricks says 700,000 new seniors have started GLP-1 treatments since Medicare coverage for obesity drugs launched in July.

In an interview with CNBC, Ricks said about 70% of those patients are taking Eli Lilly medications.

The expanded coverage has helped seniors with a high body mass index and preexisting conditions such as hypertension and prediabetes, as well as those who have previously experienced a heart attack or stroke.

Meanwhile, Disney is using discounted tickets and family-focused promotions to attract more visitors to its theme parks as Universal and SeaWorld deal with weaker traffic.

Disneyland introduced a limited-time $59 evening ticket along with resident specials, children’s offers, hotel discounts and free-dining promotions.

At Walt Disney World, Disney has offered a three-day, three-park ticket for $89 per day, or $267 total, excluding Magic Kingdom.

On Wall Street, a rally in technology stocks pushed the Nasdaq to a record close as investors bought artificial intelligence-related shares.

Paramount has also reached a settlement with state attorneys general that clears the way for its acquisition of Warner Bros. Discovery.

As part of the agreement, Paramount committed to invest at least $1.5 billion more in U.S. film and television production over the next five years. The company also agreed to provide funding for a workforce-training program for the entertainment industry.

And horror movies continue to perform strongly at the box office.

“Resident Evil” set a franchise record with a $60 million opening weekend. Other horror films, including “Obsession” and “Backrooms,” have also performed well this year.